Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy. (Record no. 10929620)

MARC details
000 -LEADER
fixed length control field 01529 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513220902.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200010s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0022-538X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1128/jvi.74.19.9028-9038.2000
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Nousbaum, J
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20001004
245 00 - TITLE STATEMENT
Title Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of virology
Date of publication, distribution, etc. Oct 2000
300 ## - PHYSICAL DESCRIPTION
Extent 9028-38 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Amino Acid Sequence
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antiviral Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy, Combination
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepacivirus
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepatitis C
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interferons
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Molecular Sequence Data
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mutation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ribavirin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Viral Nonstructural Proteins
General subdivision genetics
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Polyak, S J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ray, S C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sullivan, D G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Larson, A M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Carithers, R L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gretch, D R
773 0# - HOST ITEM ENTRY
Title Journal of virology
Related parts vol. 74
-- no. 19
-- p. 9028-38
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1128/jvi.74.19.9028-9038.2000">https://doi.org/10.1128/jvi.74.19.9028-9038.2000</a>
Public note Available from publisher's website

No items available.